GL-V9 ameliorates liver fibrosis by inhibiting TGF-β/smad pathway
Guo, Yabing, Tian, Geng, Chen, Xin, Hou, Yingjian, Zhang, Xinyu, Xue, Xin, Zhao, Li, Wu, Yun
Published in Experimental cell research (01.04.2023)
Published in Experimental cell research (01.04.2023)
Get full text
Journal Article
Camrelizumab combined with lenvatinib and RALOX-HAIC for hepatocellular carcinoma (HCC) in BCLC stage B and C: A prospective, single-arm, phase II trial (Cal Era study)
Chen, Jinzhang, Zang, Mengya, Pang, Huajin, Li, Chuanjiang, Zhao, Jianbo, Guo, Yabing, Hou, Jinlin
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran
Published in The Lancet (British edition) (30.09.2023)
Published in The Lancet (British edition) (30.09.2023)
Get full text
Journal Article
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Fan, Rong, Papatheodoridis, George, Sun, Jian, Innes, Hamish, Toyoda, Hidenori, Xie, Qing, Mo, Shuyuan, Sypsa, Vana, Guha, Indra Neil, Kumada, Takashi, Niu, Junqi, Dalekos, George, Yasuda, Satoshi, Barnes, Eleanor, Lian, Jianqi, Suri, Vithika, Idilman, Ramazan, Barclay, Stephen T., Dou, Xiaoguang, Berg, Thomas, Hayes, Peter C., Flaherty, John F., Zhou, Yuanping, Zhang, Zhengang, Buti, Maria, Hutchinson, Sharon J., Guo, Yabing, Calleja, Jose Luis, Lin, Lanjia, Zhao, Longfeng, Chen, Yongpeng, Janssen, Harry L.A., Zhu, Chaonan, Shi, Lei, Tang, Xiaoping, Gaggar, Anuj, Wei, Lai, Jia, Jidong, Irving, William L., Johnson, Philip J., Lampertico, Pietro, Hou, Jinlin
Published in Journal of hepatology (01.12.2020)
Published in Journal of hepatology (01.12.2020)
Get full text
Journal Article
Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study
Zang, Mengya, Li, Qi, Hu, Xiaoyun, Yuan, Guosheng, Li, Rong, Guo, Yabing, Chen, Jinzhang
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Qin, Shukui, Chen, Minshan, Kudo, Masatoshi, Yopp, Adam C, Wang, Lu, Tak, Won Young, Lian, Qinshu, Spahn, Jessica H, Wang, Yulei, Chow, Pierce K H, Poursoltan, Pirooz, Kiberu, Andrew, Chittajallu, Renuka, Sood, Siddarth, Stauber, Rudolf, Peck-Radosavljevic, Markus, Decaestecker, Jochen, Verset, Gontran, Cunha Júnior, Ademar, Faria, Luiza, Asselah, Jamil, Brahmania, Mayur, Li, Qiang, Chen, Zhendong, Zhao, Haitao, Liu, Hongming, Wu, Feixiang, Zheng, Qichang, Li, Haitao, Wen, Tianfu, Qin, Shukui, Liu, Yunpeng, Chen, Minshan, Bai, Yuxian, Zhao, Hong, Yin, Tao, Ding, Youming, Jia, Weidong, Xia, Yongxiang, Xia, Qiang, Guzmán, Adrián, Corrales, Luis, Kubala, Eugen, Blanc, Jean Frederic, Borg, Christophe, Decaens, Thomas, Uguen, Thomas, Heurgue, Alexandra, Trojan, Joerg, Gonzalez-Carmona, Maria Angeles, Schotten, Clemens, Kandulski, Arne, Yau, Thomas, Scartozzi, Mario, Leonardi, Francesco, Ghidini, Michele, Kudo, Masatoshi, Koga, Hironori, Kawamura, Yusuke, Hasegawa, Kiyoshi, Marusawa, Hiroyuki, Hayashi, Hiromitsu, Lee, Han Chu, Paik, Seung Woon, Kim, Do Young, Jeong, Sook-Hyang, Kim, Hyeyeong, Yoon, Seung Kew, Yoon, Jung-Hwan, Villalobos, Ricardo, Martinez Rodriguez, Jorge Luis, Oyervides Juarez, Victor, Hernández, Carlos Alberto, de Vos-Geelen, Judith, Gane, Edward, Torres Mattos, Cesar, Alyasova, Anna, Sekacheva, Marina, Ledin, Evgeny, Toh, Han Chong, Lopez Lopez, Carlos, Muñoz Martin, Andres Jesus, Reig Monzón, Maria, Delgado Mingorance, Ignacio, Minguez Rosique, Beatriz, Huang, Yi-Hsiang, Huang, Jee-Fu, Su, Wei-Wen, Maneenil, Kunlatida, Harputluoglu, Hakan, Buchschacher, Gary, Xiong, Henry, Patel, Mital, Li, Daneng, Brooks, Gabriel, Patel, Reema, Kardosh, Adel, Shah, Ashesh, Burris III, Howard, Hsiehchen, David
Published in The Lancet (British edition) (18.11.2023)
Published in The Lancet (British edition) (18.11.2023)
Get full text
Journal Article
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Llovet, Josep M, Kudo, Masatoshi, Meyer, Tim, Qin, Shukui, Ikeda, Masafumi, Ren, Zhenggang, Lim, Ho Yeong, Cheng, Ann-Lii, Galle, Peter R, Wang, Anran, Mody, Kalgi, Dutcus, Corina, Siegel, Abby B, Thompson, Alexander, Andelkovic, Vladimir, Knox, Jennifer, Davies, Janine, Asselah, Jamil, Brahmania, Mayur, Xu, Ruocai, Pan, Hongming, Gu, Kangsheng, Hao, Chunyi, Cao, Peiguo, Xiao, Juxiang, Bai, Yuxian, Chen, Xiaoming, Yan, Dong, Zhao, Hong, Bonilla, Carlos, Zambrano, Angela, Lema, Mauricio, Restrepo Gutierrez, Juan Carlos, Ramos, Victor, LeSourd, Samuel, Edeline, Julien, Bourliere, Marc, Regnault, Helene, Dauvois, Barbara, Schulze, Kornelius, Waidmann, Oliver, Berres, Marie-Luise, Berg, Thomas, Waldschmidt, Dirk T, Bitzer, Michael, Duffy, Austin, Tonini, Giuseppe, Rizzo, Mimma, Biscaldi, Elisa, Ikeda, Masafumi, Kudo, Masatoshi, Numata, Kazushi, Marusawa, Hiroyuki, Kato, Naoya, Morimoto, Manabu, Yamashita, Tatsuya, Koga, Hironori, Masaki, Tsutomu, Tateishi, Ryosuke, Inaba, Yoshitaka, Arakawa, Tomohiro, Suzuki, Yoshiyuki, Hosaka, Tetsuya, Ryoo, Baek-Yeol, Lim, Ho Yeong, Kim, Tae-You, Hernandez Hernandez, Carlos, Motola Kuba, Daniel, Segura Gonzalez, Manuel, Cabrera Luviano, Jesus, Ramirez Godinez, Francisco, Stedman, Catherine, Wyrwicz, Lucjan, Kraj, Leszek, Surma-Wlodarczyk, Renata, Breder, Valeriy, Sekacheva, Marina, Orlova, Rashida, Vasilyev, Alexander, Zukov, Ruslan, Minguez, Beatriz, Matilla Pena, Ana, Fernandez Castroagudin, Javier, Garcia Sanchez, Araceli, Jeng, Long-Bin, Dechaphunkul, Arunee, Seker, Mesut, Bilici, Mehmet, Cil, Timucin, Ulahannan, Susanna, Zakari, Ahmed, Feun, Lynn, Al-Rajabi, Raed, Sung, Max, Kardosh, Adel, Dodlapati, Jyothi, Agrawal, Saurabh, Gopaluni, Srivalli, Loaiza-Bonilla, Arturo, Frenette, Catherine
Published in The lancet oncology (01.12.2023)
Published in The lancet oncology (01.12.2023)
Get full text
Journal Article
Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial
Qin, Shukui, Kudo, Masatoshi, Meyer, Tim, Bai, Yuxian, Guo, Yabing, Meng, Zhiqiang, Satoh, Taroh, Marino, Donatella, Assenat, Eric, Li, Songzi, Chen, Yaxi, Boisserie, Frederic, Abdrashitov, Ramil, Finn, Richard S, Vogel, Arndt, Zhu, Andrew X
Published in JAMA oncology (01.12.2023)
Published in JAMA oncology (01.12.2023)
Get more information
Journal Article
Rheology characteristics of activated sludge and thermal treated sludge at different process temperature
Feng, GuoHong, Ma, He, Bai, Tiantian, Guo, Yabing
Published in Water science and technology (01.04.2018)
Published in Water science and technology (01.04.2018)
Get full text
Journal Article
Unexpected high retention of 15N‐labeled nitrogen in a tropical legume forest under long‐term nitrogen enrichment
Mao, Jinhua, Mao, Qinggong, Gundersen, Per, Gurmesa, Geshere A., Zhang, Wei, Huang, Juan, Wang, Senhao, Li, Andi, Wang, Yufang, Guo, Yabing, Liu, Rongzhen, Mo, Jiangming, Zheng, Mianhai
Published in Global change biology (01.02.2022)
Published in Global change biology (01.02.2022)
Get full text
Journal Article
ORIENT-32: Updated characterization of response to sintilimab plus bevacizumab biosimilar (IBI305) vs sorafenib for unresectable hepatocellular carcinoma
Ren, Zhenggang, Xu, Jianming, Bai, Yuxian, Xu, Aibing, Cang, Shundong, Du, Chengyou, Liu, Baorui, Li, Qiu, Lu, Yinying, Chen, Yajin, Shao, Guoliang, Guo, Yabing, Chen, Zhendong, Fan, Jia
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Report of adverse events of special interest (AESIs) for sintilimab plus a bevacizumab biosimilar (IBI305) in unresectable hepatocellular carcinoma
Ren, Zhenggang, Xu, Jianming, Bai, Yuxian, Xu, Aibing, Cang, Shundong, Du, Chengyou, Liu, Baorui, Li, Qiu, Lu, Yinying, Chen, Yajin, Shao, Guoliang, Guo, Yabing, Chen, Zhendong, Fan, Jia
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
The efficacy and safety of transarterial chemoembolization combined with cadonilimab and lenvatinib for unresectable hepatocellular carcinoma: A phase II clinical trial
Liang, Guo, Gu, Shanzhi, Guo, Yabing, Li, Hailiang, Liu, Jingfeng, Liu, Jibing, Huang, Ming, Zou, Yinghua, Huang, Luke, Zhang, Yangyang, Liu, Ting, Liu, Wei, Wang, Zhongmin, Li, Baiyong, Xia, Yu
Published in Journal of clinical oncology (20.01.2024)
Published in Journal of clinical oncology (20.01.2024)
Get full text
Journal Article
AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein-1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus TIS plus BAT1706 as first-line (1L) treatment for advanced hepatocellular carcinoma (HCC)
Fan, Jia, Ren, Zhenggang, Hsu, Chiun, Guo, Yabing, Song, Tianqiang, Wang, Wentao, Chao, Yee, Gao, Yujuan, Li, Vincent, Ferro, Salvatore, Yen, Chia-Jui
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy
Liu, Shi, Deng, Rui, Zhou, Bin, Liang, Xieer, Liu, Zhihong, Peng, Jie, Chen, Jinjun, Zhou, Yuanping, Guo, Yabing, Chen, Yongpeng, Li, Wanying, Shen, Sheng, Lu, Xingyu, Zhao, Siru, Liao, Xingmei, Liang, Hongyan, Lan, Yu, Hou, Jinlin, Fan, Rong, Sun, Jian
Published in The Journal of infectious diseases (13.09.2022)
Published in The Journal of infectious diseases (13.09.2022)
Get full text
Journal Article
AdvanTIG-206: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (BGB-A1217; OCI) plus anti-programmed cell death protein 1 (PD-1) mAb tislelizumab (TIS) plus BAT1706 versus (vs) TIS plus BAT1706 as first-line treatment for advanced hepatocellular carcinoma (HCC)
Fan, Jia, Ren, Zhenggang, Hsu, Chiun, Guo, Yabing, Song, Tianqiang, Wang, Wentao, Chao, Yee, Gao, Yujuan, Li, Bai, Ferro, Salvatore, Yen, Chia-Jui
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
TALENTACE: A phase III, open-label, randomized study of on-demand transarterial chemoembolization combined with atezolizumab + bevacizumab or on-demand transarterial chemoembolization alone in patients with untreated hepatocellular carcinoma
Kudo, Masatoshi, Guo, Yabing, Hua, Yongqiang, Zhao, Ming, Xing, Wenge, Zhang, Yonghong, Liu, Ruibao, Ren, Zhenggang, Gu, Shanzhi, Lin, Zhengyu, Lv, Weifu, Wang, Yumeng, Dong, Jiahong
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article
A phase Ib study of porustobart (HBM4003), an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in patients with hepatocellular carcinoma
Zhang, Ningning, Qin, Shukui, Guo, Yabing, Xu, Zhongyuan, Zhang, Yanqiao, Yao, Jun, Gu, Shanzhi, Shen, Jie, Xu, Aibing, Chen, Yajin, Xin, Guijie, Yu, Ge, Wang, Gang, Zhang, Jingdong, Gardner, Humphrey, Ding, Luyin, Zhao, Shuai, Yang, Dian, Lu, Wei, Hao, Jihui
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
An open-label, multicenter, adaptive, phase Ib/II study of QL1706 or QL1604 plus bevacizumab as first-line treatment in patients with advanced hepatocellular carcinoma
Bi, Feng, Zhang, Yan-qiao, Gu, Shanzhi, Guo, Yabing, Xu, Zhongyuan, Ying, Hao, Da, Mingxu, Liu, Chaoying, Pan, Yaozhen, Huang, Yao, Chen, Zhiyu, Wang, Zheng, Wu, Jianbing, Weng, Shangeng, Wang, Yanjun, Zhao, Jun, Yu, Xiaokui, Li, Hui, Xue, Shilin, Kang, Xiaoyan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article